Advertisements



Hedge Funds Are Betting On Bristol Myers Squibb Co. (BMY)

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual i.....»»

Category: topSource: insidermonkeyDec 7th, 2018

Is Bristol Myers Squibb Co. (BMY) A Good Stock To Buy According To Hedge Funds?

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual i.....»»

Category: topSource: insidermonkeyDec 8th, 2018

Wellington Management Company To Vote Against BMY Merger

Celgene Corporation (CELG)’s stock falls after Wellington Management Company announced that it does not support Bristol-Myers Squibb Co (BMY)’s proposed acquisition. Q4 hedge.....»»

Category: blogSource: valuewalkFeb 28th, 2019

Starboard to vote against Bristol-Myers-Celgene $74 billion deal

Activist investor Starboard Value LP will vote against Bristol-Myers Squibb Co's $74 billion acquisition of Celgene Corp, the hedge fund said on Thursday, adding to the number of shareholders declaring against the deal......»»

Category: topSource: reutersFeb 28th, 2019

Bristol-Myers says Starboard nominated five directors, bought shares

Bristol-Myers Squibb Co. said on Wednesday that activist hedge fund Starboard Value LP wants to add five directors to its board and bought one million shares after the pharmaceutical company said it plans to buy biotech company Celgene Corp......»»

Category: topSource: reutersFeb 20th, 2019

Starboard gauges Bristol-Myers shareholder support for Celgene deal

Activist hedge fund Starboard Value LP has asked a proxy solicitor to probe the level of support among Bristol-Myers Squibb Co shareholders for the U.S. drug maker's $74 billion deal to buy Celgene Corp, people familiar with the matter said on Friday......»»

Category: topSource: reutersFeb 15th, 2019

Stada, buyout funds in race for Bristol-Myers" French business: sources

German generic drugmaker Stada is vying with a group of European buyout funds for control of Bristol-Myers Squibb's French over-the-counter drugs business, sources familiar with the matter told Reuters......»»

Category: topSource: reutersOct 8th, 2018

Without A Buyer For Bristol-Myers, Starboard’s Recipe Looks Less Substantial

Could Starboard Value‘s “nutritional broth for cells” be to Bristol-Myers Squibb what salting the water was to Olive Garden? This week, the activist published a 197-slide presentation outlining its objections to the merger of Bristol-Myers and .....»»

Category: blogSource: valuewalkMar 22nd, 2019

These Hedge Funds Were Right Betting On Corindus Vascular Robotics Inc (CVRS)

It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 50.....»»

Category: topSource: insidermonkeyMar 22nd, 2019

Bristol-Myers Squibb and Starboard Value square off over Celgene deal

L.....»»

Category: topSource: bizjournalsMar 19th, 2019

For Bristol-Myers Squibb"s Sake, Celgene Merger Should Be Voted Down

For Bristol-Myers Squibb"s Sake, Celgene Merger Should Be Voted Down.....»»

Category: topSource: seekingalphaMar 15th, 2019

Bristol-Myers Squibb Company (BMY) Management Presents at Barclays 2019 Global Healthcare Conference Call (Transcript)

Bristol-Myers Squibb Company (BMY) Management Presents at Barclays 2019 Global Healthcare Conference Call (Transcript).....»»

Category: topSource: seekingalphaMar 13th, 2019

Bristol-Myers Squibb Co."s (BMY) CEO Giovanni Caforio Presents at Cowen Health Care Conference Call (Transcript)

Bristol-Myers Squibb Co."s (BMY) CEO Giovanni Caforio Presents at Cowen Health Care Conference Call (Transcript).....»»

Category: topSource: seekingalphaMar 13th, 2019

Bristol-Myers Squibb Co. (BMY) Presents at Cowen Health Care Broker Conference Call (Transcript)

Bristol-Myers Squibb Co. (BMY) Presents at Cowen Health Care Broker Conference Call (Transcript).....»»

Category: topSource: seekingalphaMar 12th, 2019

Bristol Myers Squibb call buyer realizes 58% same-day gains

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 11th, 2019

A Closer Look At The Shareholder Makeup Of Bristol-Myers Squibb

A Closer Look At The Shareholder Makeup Of Bristol-Myers Squibb.....»»

Category: topSource: seekingalphaMar 8th, 2019

Bristol-Myers Squibb Takes Over #65 Spot From Lowe"s Companies

Market News Video.....»»

Category: topSource: redinewsMar 2nd, 2019

The Bristol-Myers--Squibb Deal May No Longer Be a Sure Thing, but It Will Still Likely Happen

Amid strong opposition to the Big Pharma merger, Bristol-Myers faces three scenarios, none of them pretty, writes UBS’s Navin Jacob......»»

Category: topSource: barronsMar 2nd, 2019

Bristol-Myers tries to salvage $74 billion deal with Celgene

Bristol-Myers Squibb is meeting with shareholders in Boston and New York as its $74 billion purchase of drugmaker Celgene is at risk of being derailed......»»

Category: topSource: moneycentralMar 1st, 2019

Celgene Stock Tumbles After Bristol-Myers Squibb Shareholder Opposes Takeover

Wellington Management cited the deal’s price and a preference for other methods of value creation in opposing Bristol-Myers Squibb’s takeover of Celgene......»»

Category: topSource: barronsFeb 28th, 2019

Starboard joins opposition to Bristol-Myers" $74 billion Celgene deal

Activist hedge fund Starboard Value .....»»

Category: topSource: reutersFeb 28th, 2019